The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Tryptophan Metabolism as a Pharmacological Target
Open accessAbstract
L-Tryptophan is an essential amino acid required for protein synthesis. It undergoes an extensive and complex metabolism along several pathways, resulting in many bioactive molecules acting in various organs through different action mechanisms. Enzymes involved in its metabolism, metabolites themselves, or their receptors, represent potential therapeutic targets, which are the subject of dynamic research. Disruptions in L-tryptophan metabolism are reported in several neurological, metabolic, psychiatric, and intestinal disorders, paving the way to develop drugs to target it. This review will briefly describe L-tryptophan metabolism and present and discuss the most recent pharmacological developments targeting it.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
The Parkinson's disease death rate: carbidopa and vitamin B6
Hinz, M., Stein, A. L., & Cole, T. (2014) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s70707 · Cited by 25
RetractedIndigenous bacteria from the gut microbiota regulate host serotonin biosynthesis
Yano, J. M., Yu, K., Donaldson, G. P., Shastri, G. G., Ann, P., Ma, L., Nagler, C. R., Ismagilov, R. F., Mazmanian, S. K., & Hsiao, E. Y. (2015) · Cell · doi:10.1016/j.cell.2015.02.047 · Cited by 3,614
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180
Self-citationUyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Platten, M., Nollen, E. A. A., Röhrig, U. F., Fallarino, F., & Opitz, C. A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0016-5 · Cited by 1,586
Lamas, B., Richard, M. L., Leducq, V., Pham, H.-P., Michel, M.-L., Da Costa, G., Bridonneau, C., Jegou, S., Hoffmann, T. W., Natividad, J. M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4102 · Cited by 1,482
Self-citationReigstad, C. S., Salmonson, C. E., III, J. F. R., Szurszewski, J. H., Linden, D. R., Sonnenburg, J. L., Farrugia, G., & Kashyap, P. C. (2015) · The FASEB Journal · doi:10.1096/fj.14-259598 · Cited by 1,335
Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects
Badawy, A. A.-B. (2017) · International Journal of Tryptophan Research · doi:10.1177/1178646917691938 · Cited by 1,158
Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells
Boitano, A. E., Wang, J., Romeo, R., Bouchez, L. C., Parker, A. E., Sutton, S. E., Walker, J. R., Flaveny, C. A., Perdew, G. H., Denison, M. S., et al. (2010) · Science · doi:10.1126/science.1191536 · Cited by 1,047
Next-generation probiotics: the spectrum from probiotics to live biotherapeutics
O’Toole, P. W., Marchesi, J. R., & Hill, C. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.57 · Cited by 971
Long, G. V., Dummer, R., Hamid, O., Gajewski, T. F., Caglevic, C., Dalle, S., Arance, A., Carlino, M. S., Grob, J.-J., Kim, T. M., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30274-8 · Cited by 960
Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation
Wlodarska, M., Luo, C., Kolde, R., d’Hennezel, E., Annand, J. W., Heim, C. E., Krastel, P., Schmitt, E. K., Omar, A. S., Creasey, E. A., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.06.007 · Cited by 882
Natividad, J. M., Agus, A., Planchais, J., Lamas, B., Jarry, A. C., Martin, R., Michel, M.-L., Chong-Nguyen, C., Roussel, R., Straube, M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.001 · Cited by 642
Self-citationRosser, E. C., Piper, C. J. M., Matei, D. E., Blair, P. A., Rendeiro, A. F., Orford, M., Alber, D. G., Krausgruber, T., Catalan, D., Klein, N., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.03.003 · Cited by 579
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
Pilotte, L., Larrieu, P., Stroobant, V., Colau, D., Dolušić, E., Frédérick, R., De Plaen, E., Uyttenhove, C., Wouters, J., Masereel, B., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113873109 · Cited by 572
IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression
Sadik, A., Somarribas Patterson, L. F., Öztürk, S., Mohapatra, S. R., Panitz, V., Secker, P. F., Pfänder, P., Loth, S., Salem, H., Prentzell, M. T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.038 · Cited by 559
Feedback control of AHR signalling regulates intestinal immunity
Schiering, C., Wincent, E., Metidji, A., Iseppon, A., Li, Y., Potocnik, A. J., Omenetti, S., Henderson, C. J., Wolf, C. R., Nebert, D. W., et al. (2017) · Nature · doi:10.1038/nature21080 · Cited by 540
Liu, Y., Liang, X., Dong, W., Fang, Y., Lv, J., Zhang, T., Fiskesund, R., Xie, J., Liu, J., Yin, X., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.02.005 · Cited by 535
Aryl hydrocarbon receptor and intestinal immunity
Lamas, B., Natividad, J. M., & Sokol, H. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0019-2 · Cited by 516
Self-citationTargeting the IDO1/TDO2–KYN–AhR Pathway for Cancer Immunotherapy – Challenges and Opportunities
Cheong, J. E., & Sun, L. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.11.007 · Cited by 487
Bhattarai, Y., Williams, B. B., Battaglioli, E. J., Whitaker, W. R., Till, L., Grover, M., Linden, D. R., Akiba, Y., Kandimalla, K. K., Zachos, N. C., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.004 · Cited by 436
De novo NAD+ synthesis enhances mitochondrial function and improves health
Katsyuba, E., Mottis, A., Zietak, M., De Franco, F., van der Velpen, V., Gariani, K., Ryu, D., Cialabrini, L., Matilainen, O., Liscio, P., et al. (2018) · Nature · doi:10.1038/s41586-018-0645-6 · Cited by 430
Mitchell, T. C., Hamid, O., Smith, D. C., Bauer, T. M., Wasser, J. S., Olszanski, A. J., Luke, J. J., Balmanoukian, A. S., Schmidt, E. V., Zhao, Y., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.9602 · Cited by 388
Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans.
Smith, S. H., Jayawickreme, C., Rickard, D. J., Nicodeme, E., Bui, T., Simmons, C., Coquery, C. M., Neil, J., Pryor, W. M., Mayhew, D., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.05.004 · Cited by 387
Next generation probiotics in disease amelioration
Chang, C.-J., Lin, T.-L., Tsai, Y.-L., Wu, T.-R., Lai, W.-F., Lu, C.-C., & Lai, H.-C. (2019) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2018.12.011 · Cited by 369
Emerging Health Concepts in the Probiotics Field: Streamlining the Definitions
Martín, R., & Langella, P. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01047 · Cited by 363
Tranilast: A review of its therapeutic applications
Darakhshan, S., & Pour, A. B. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2014.10.009 · Cited by 322
Kynurenic Acid and Gpr35 Regulate Adipose Tissue Energy Homeostasis and Inflammation
Agudelo, L. Z., Ferreira, D. M. S., Cervenka, I., Bryzgalova, G., Dadvar, S., Jannig, P. R., Pettersson-Klein, A. T., Lakshmikanth, T., Sustarsic, E. G., Porsmyr-Palmertz, M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.004 · Cited by 302
Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health
Laurans, L., Venteclef, N., Haddad, Y., Chajadine, M., Alzaid, F., Metghalchi, S., Sovran, B., Denis, R. G. P., Dairou, J., Cardellini, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0060-4 · Cited by 300
Self-citationKindler, J., Lim, C. K., Weickert, C. S., Boerrigter, D., Galletly, C., Liu, D., Jacobs, K. R., Balzan, R., Bruggemann, J., O’Donnell, M., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0401-9 · Cited by 284
Immune control by amino acid catabolism during tumorigenesis and therapy
Lemos, H., Huang, L., Prendergast, G. C., & Mellor, A. L. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0106-z · Cited by 274
Lim, C. K., Bilgin, A., Lovejoy, D. B., Tan, V., Bustamante, S., Taylor, B. V., Bessede, A., Brew, B. J., & Guillemin, G. J. (2017) · Scientific Reports · doi:10.1038/srep41473 · Cited by 255
Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis
Plitman, E., Iwata, Y., Caravaggio, F., Nakajima, S., Chung, J. K., Gerretsen, P., Kim, J., Takeuchi, H., Chakravarty, M. M., Remington, G., et al. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw221 · Cited by 251
Universal model of individual and population mobility on diverse spatial scales
Yan, X.-Y., Wang, W.-X., Gao, Z.-Y., & Lai, Y.-C. (2017) · Nature Communications · doi:10.1038/s41467-017-01892-8 · Cited by 247
Wang, G., Cao, K., Liu, K., Xue, Y., Roberts, A. I., Li, F., Han, Y., Rabson, A. B., Wang, Y., & Shi, Y. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0006-2 · Cited by 214
Savitz, J., Drevets, W. C., Wurfel, B. E., Ford, B. N., Bellgowan, P. S. F., Victor, T. A., Bodurka, J., Teague, T. K., & Dantzer, R. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.02.007 · Cited by 209
Brundin, L., Sellgren, C. M., Lim, C. K., Grit, J., Pålsson, E., Landén, M., Samuelsson, M., Lundgren, K., Brundin, P., Fuchs, D., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.133 · Cited by 195
A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
On behalf of the BRAVO Study Group, Vollmer, T. L., Sorensen, P. S., Selmaj, K., Zipp, F., Havrdova, E., Cohen, J. A., Sasson, N., Gilgun-Sherki, Y., & Arnold, D. L. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7264-4 · Cited by 194
Reduction of Brain Kynurenic Acid Improves Cognitive Function
Kozak, R., Campbell, B. M., Strick, C. A., Horner, W., Hoffmann, W. E., Kiss, T., Chapin, D. S., McGinnis, D., Abbott, A. L., Roberts, B. M., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1107-14.2014 · Cited by 180
Fujigaki, H., Yamamoto, Y., & Saito, K. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.011 · Cited by 178
Sahm, F., Oezen, I., Opitz, C. A., Radlwimmer, B., von Deimling, A., Ahrendt, T., Adams, S., Bode, H. B., Guillemin, G. J., Wick, W., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3831 · Cited by 174
Jennis, M., Cavanaugh, C. R., Leo, G. C., Mabus, J. R., Lenhard, J., & Hornby, P. J. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13178 · Cited by 171
Lewis-Ballester, A., Pham, K. N., Batabyal, D., Karkashon, S., Bonanno, J. B., Poulos, T. L., & Yeh, S.-R. (2017) · Nature Communications · doi:10.1038/s41467-017-01725-8 · Cited by 165
Peppers, J., Paller, A. S., Maeda-Chubachi, T., Wu, S., Robbins, K., Gallagher, K., & Kraus, J. E. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.06.047 · Cited by 165
Harden, J. L., Lewis, S. M., Lish, S. R., Suárez‐Fariñas, M., Gareau, D. S., Lentini, T., Johnson-Huang, L. M., Krueger, J. G., & Lowes, M. A. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.09.055 · Cited by 160
Garrison, A. M., Parrott, J. M., Tuñon, A., Delgado, J., Redus, L., & O’Connor, J. C. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.04.019 · Cited by 160
Nayak-Kapoor, A., Hao, Z., Sadek, R., Dobbins, R., Marshall, L., Vahanian, N. N., Jay Ramsey, W., Kennedy, E., Mautino, M. R., Link, C. J., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0351-9 · Cited by 160
Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease
Lim, C. K., Fernández-Gomez, F. J., Braidy, N., Estrada, C., Costa, C., Costa, S., Bessede, A., Fernandez-Villalba, E., Zinger, A., Herrero, M. T., et al. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.009 · Cited by 159
Mole, D. J., Webster, S. P., Uings, I., Zheng, X., Binnie, M., Wilson, K., Hutchinson, J. P., Mirguet, O., Walker, A., Beaufils, B., et al. (2016) · Nature Medicine · doi:10.1038/nm.4020 · Cited by 159
Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson’s Disease
Chang, K., Cheng, M., Tang, H.-Y., Huang, C.-Y., Wu, Y., & Chen, C. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0845-3 · Cited by 155
Kaye, J., Piryatinsky, V., Birnberg, T., Hingaly, T., Raymond, E., Kashi, R., Amit‐Romach, E., Caballero, I. S., Towfic, F., Ator, M. A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607843113 · Cited by 146
A phase I study of indoximod in patients with advanced malignancies
Soliman, H. H., Minton, S. E., Han, H. S., Ismail-Khan, R. R., Neuger, A. M., Khambati, F. A., Noyes, D. R., Lush, R. M., Chiappori, A., Roberts, J. D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8216 · Cited by 145
Crosignani, S., Bingham, P., Bottemanne, P., Cannelle, H., Cauwenberghs, S., Cordonnier, M., Dalvie, D., Deroose, F. D., Feng, J. L., Gomes, B., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00974 · Cited by 144
Does kynurenic acid act on nicotinic receptors? An assessment of the evidence
Stone, T. W. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14907 · Cited by 123
Fazio, F., Lionetto, L., Curto, M., Iacovelli, L., Cavallari, M., Zappulla, C., Ulivieri, M., Napoletano, F., Capi, M., Corigliano, V., et al. (2015) · Scientific Reports · doi:10.1038/srep17799 · Cited by 119
Zanos, P., Piantadosi, S. C., Wu, H., Pribut, H. J., Dell, M. J., Can, A., Snodgrass, H. R., Zarate, C. A., Schwarcz, R. M., & Gould, T. D. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.225664 · Cited by 114
Lim, C. K., Essa, M. M., Martins, R. D. P., Lovejoy, D. B., BILGIN, A. A. B., Waly, M. I., Al-Farsi, Y. M., Al‐Sharbati, M. M., Al‐Shaffae, M. A., & Guillemin, G. J. (2015) · Autism Research · doi:10.1002/aur.1565 · Cited by 106
Kristeleit, R. S., Давиденко, І., Shirinkin, V., El-Khouly, F., Bondarenko, I., Goodheart, M. J., Горбунова, В. А., Penning, C. A., Shi, J. G., Liu, X., et al. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.07.005 · Cited by 102
Beneficial actions of microbiota‐derived tryptophan metabolites
Galligan, J. J. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13283 · Cited by 99
Robbins, K., Bissonnette, R., Maeda‐Chubachi, T., Ye, L., Peppers, J., Gallagher, K., & Kraus, J. E. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.10.037 · Cited by 98
Dounay, A. B., Anderson, M. D., Bechle, B. M., Campbell, B. M., Claffey, M. M., Evdokimov, A. G., Evrard, E., Fonseca, K. R., Gan, X., Ghosh, S., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200204m · Cited by 89
Siu, L. L., Gelmon, K. A., Chu, Q. S.-C., Pachynski, R. K., Alese, O. B., Basciano, P. A., Walker, J., Mitra, P., Zhu, L., Phillips, P., et al. (2017) · Cancer Research · doi:10.1158/1538-7445.am2017-ct116 · Cited by 88
Indole-3-Propionic Acid, a Tryptophan-Derived Bacterial Metabolite, Reduces Weight Gain in Rats
Konopelski, P., Konop, M., Gawryś-Kopczyńska, M., Podsadni, P., Szczepańska, A., & Ufnal, M. (2019) · Nutrients · doi:10.3390/nu11030591 · Cited by 87
Role of Nicotinamide in Genomic Stability and Skin Cancer Chemoprevention
Fania, L., Mazzanti, C., Campione, E., Candi, E., ABENI, D. D., & Dellambra, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235946 · Cited by 87
Melatonin's role as a co-adjuvant treatment in colonic diseases: A review
Zubero, E. E., López‐Pingarrón, L., Alatorre-Jiménez, M. A., Ochoa-Moneo, P., Celia, B.-R., Rivas-Jiménez, M., Castán-Ruiz, S., Antoñanzas-Lombarte, Á., Tan, D., García, J. J., et al. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.11.031 · Cited by 85
Kurata, K., Kawahara, H., Nishimura, K., Jisaka, M., Yokota, K., & Shimizu, H. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.01.122 · Cited by 85
Kynurenic Acid Levels are Increased in the CSF of Alzheimer’s Disease Patients
González-Sánchez, M., Jiménez, J., Narváez, A., Antequera, D., Llamas-Velasco, S., Martín, A. H.-S., Molina Arjona, J. A., López de Munain, A., Lleó Bisa, A., Marco, M.-P., et al. (2020) · Biomolecules · doi:10.3390/biom10040571 · Cited by 84
A phase II study of laquinimod in Crohn's disease
D’Haens, G., Sandborn, W. J., Colombel, J., Rutgeerts, P. J., Brown, K. A., Barkay, H., Sakov, A., Haviv, A., & Feagan, B. G. (2014) · Gut · doi:10.1136/gutjnl-2014-307118 · Cited by 83
Sun, J., Chen, Y., Huang, Y., Zhao, W., Liu, Y., Venkataramanan, R., Lu, B., & Li, S. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.44 · Cited by 78
Kim, J., Wang, H., Terc, J. D., Zambrowicz, B., Yang, Q., & Khan, W. I. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00299.2014 · Cited by 69
Toledo, L. M., Prime, M. E., Mrzljak, L., Beconi, M. G., Beresford, A. P., Brookfield, F. A., Brown, C. J., Cardaun, I., Courtney, S. M., Dijkman, U., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501350y · Cited by 67
Major Developments in the Design of Inhibitors along the Kynurenine Pathway
Jacobs, K. R., Castellano‐González, G., Guillemin, G. J., & Lovejoy, D. B. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170502123114 · Cited by 66
Beaumont, V., Mrzljak, L., Dijkman, U., Freije, R., Heins, M., Rassoulpour, A., Tombaugh, G. C., Gelman, S., Bradaïa, A., Steidl, E., et al. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.005 · Cited by 64
Park, L. T., Kadriu, B., Gould, T. D., Zanos, P., Greenstein, D., Evans, J. W., Yuan, P., Farmer, C. A., Oppenheimer, M., George, J. M., et al. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa025 · Cited by 63
Pocivavsek, A., Elmer, G. I., & Schwarcz, R. M. (2018) · Hippocampus · doi:10.1002/hipo.23040 · Cited by 62
Zhang, S., Sakuma, M., Deora, G. S., Levy, C., Klausing, A. D., Breda, C., Read, K. D., Edlin, C. D., Ross, B. P., Muelas, M. W., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0520-5 · Cited by 62
Reardon, D. A., Desjardins, A., Rixe, O., Cloughesy, T. F., Alekar, S., Williams, J. H., Li, R., Taylor, C. T., & Lassman, A. B. (2020) · Investigational New Drugs · doi:10.1007/s10637-020-00950-1 · Cited by 61
Parks, A. J., Pollastri, M. P., Hahn, M. E., Stanford, E. A., Novikov, O., Franks, D. G., Haigh, S. E., Narasimhan, S., Ashton, T. D., Hopper, T. G., et al. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.093369 · Cited by 60
Serafini, M. T., Torre, E., Aprile, S., Grosso, E. D., Gesù, A., Griglio, A., Colombo, G., Travelli, C., Paiella, S., Adamo, A., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01809 · Cited by 58
Pyridoxal 5′-Phosphate-Dependent Enzymes at the Crossroads of Host–Microbe Tryptophan Metabolism
Cellini, B., Zelante, T., Dindo, M., Bellet, M. M., Renga, G., Romani, L. R., & Costantini, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165823 · Cited by 55
Rossi, F., Casazza, V., Garavaglia, S., Sathyasaikumar, K. V., Schwarcz, R. M., Kojima, S., Okuwaki, K., Ono, S.-I., Kajii, Y., & Rizzi, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100464k · Cited by 53
Epacadostat plus nivolumab for advanced melanoma: Updated phase 2 results of the ECHO-204 study.
DAUD, A. I., Saleh, M. N., Hu, J. S., Bleeker, J. S., Riese, M. J., Meier, R., Zhou, L., Serbest, G., & Lewis, K. D. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.15_suppl.9511 · Cited by 52
Dolciami, D., Ballarotto, M., Gargaro, M., Lopez-Cara, L. C., Fallarino, F., & Macchiarulo, A. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111842 · Cited by 52
Hutchinson, J. P., Rowland, P., Taylor, M. R. D., Christodoulou, E., Haslam, C. P., Hobbs, C. I., Holmes, D. S., Homes, P., Liddle, J., Mole, D. J., et al. (2017) · Nature Communications · doi:10.1038/ncomms15827 · Cited by 51
Rojewska, E., Piotrowska, A., Makuch, W., Przewłocka, B., & Mika, J. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.040 · Cited by 50
Pellicciari, R., Liscio, P., Giacchè, N., Franco, F., Carotti, A., Robertson, J., Cialabrini, L., Katsyuba, E., Raffaelli, N., & Auwerx, J. H. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01254 · Cited by 49
Fukuwatari, T. (2020) · Nutrients · doi:10.3390/nu12051403 · Cited by 49
Roles of UGT, P450, and Gut Microbiota in the Metabolism of Epacadostat in Humans
Boer, J., Young-Sciame, R., Lee, F., Bowman, K. J., Yang, X., Shi, J., Nedza, F. M., Frietze, W. E., Galya, L. G., Combs, A. P., et al. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.070680 · Cited by 48
Shin, H., Bang, S., Kim, J., Jun, J. H., Song, H., & Lim, H. J. (2017) · Scientific Reports · doi:10.1038/srep44973 · Cited by 46
Dudzińska, E., Szymona, K., Kloc, R., Gil-Kulik, P., Kocki, T., Świstowska, M., Bogucki, J., Kocki, J., & Urbańska, E. M. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819881304 · Cited by 43
Serotonin Modulates AhR Activation by Interfering with CYP1A1-Mediated Clearance of AhR Ligands
Manzella, C. R., Ackerman, M. T., Singhal, M., Ticho, A. L., Ceh, J., Alrefai, W. A., Saksena, S., Dudeja, P. K., & Gill, R. K. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000209 · Cited by 42
Discovery of indoximod prodrugs and characterization of clinical candidate NLG802
Kumar, S., Jaipuri, F. A., Waldo, J. P., Potturi, H., Marcinowicz, A., Adams, J., Allen, C. V., Zhuang, H., Vahanian, N. N., Link, C., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112373 · Cited by 39
Yoshida, Y., Fujigaki, H., Kato, K., Yamazaki, K., Fujigaki, S., Kunisawa, K., Yamamoto, Y., Mouri, A., Oda, A., Nabeshima, T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46666-y · Cited by 33
Wallace, M. S., White, A., Grako, K. A., Lane, R., Cato, A., & Snodgrass, H. R. (2017) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2017.05.004 · Cited by 32
Liu, Y., Feng, X., Lai, J., Yi, W., Yang, J., Du, T., Long, X., Zhang, Y., & Xiao, Y. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14547 · Cited by 31
The Immunomodulator 1-Methyltryptophan Drives Tryptophan Catabolism Toward the Kynurenic Acid Branch
Wirthgen, E., Leonard, A. K., Scharf, C., & Domańska, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00313 · Cited by 31
Pellicciari, R., Venturoni, F., Bellocchi, D., Carotti, A., Marinozzi, M., Macchiarulo, A., Amori, L., & Schwarcz, R. M. (2008) · ChemMedChem · doi:10.1002/cmdc.200800109 · Cited by 30
Nassan, F. L., Gunn, J. A., Hill, M. M., Coull, B. A., & Hauser, R. B. (2019) · Environmental Research · doi:10.1016/j.envres.2019.02.034 · Cited by 21
Laquinimod Supports Remyelination in Non-Supportive Environments
Nyamoya, S., Steinle, J., Chrzanowski, U., Kaye, J., Schmitz, C., Beyer, C., & Kipp, M. (2019) · Cells · doi:10.3390/cells8111363 · Cited by 19
Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS
Ziemssen, T., Tumani, H., Sehr, T., Thomas, K., Paul, F., Richter, N., Samara, E. E., Spiegelstein, O., Sorani, E., Bar‐Ilan, O., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0945-z · Cited by 18
Leja‐Szpak, A., Góralska, M., Link‐Lenczowski, P., Czech, U., Nawrot‐Porąbka, K., Bonior, J., & Jaworek, J. M. (2019) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520619666190415165212 · Cited by 16
Papp, A. A., Hartwell, R., Evans, M. H., & Ghahary, A. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.01.023 · Cited by 15
Substrate and inhibitor specificity of kynurenine monooxygenase from Cytophaga hutchinsonii
Phillips, R. S., Anderson, A. D., Gentry, H. G., Güner, O. F., & Bowen, J. P. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.02.080 · Cited by 14
Zhang, M. H., Stone, E. M., Triplett, T., Triplett, K. C., Lamb, C., Karamitros, C. S., Blazeck, J., Georgiou, G., & Manfredi, M. G. (2017) · Cancer Research · doi:10.1158/1538-7445.am2017-5570 · Cited by 7
Stone, E. M., Marshall, N., Donkor, M. K., Triplett, K. C., Blazeck, J., Triplett, T., Ehrlich, L. I. R., & Georgiou, G. (2015) · Cancer Research · doi:10.1158/1538-7445.am2015-lb-226 · Cited by 5
Cited by
Tryptophan metabolism in health and disease
Xue, C., Li, G., Zheng, Q., Gu, X., Shi, Q., Su, Y., Chu, Q., Yuan, X., Bao, Z., Lu, J., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.004 · Cited by 961
Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives
Liu, J., Tan, Y., Cheng, H., Zhang, D., Feng, W., & Peng, C. (2022) · Aging and disease · doi:10.14336/ad.2022.0104 · Cited by 529
Correia, A. S., & Vale, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158493 · Cited by 350
Fong, W., Li, Q., Ji, F., Liang, W., Lau, H. C. H., Kang, X., Liu, W., To, K. K.-W., Zuo, Z., Li, X., et al. (2023) · Gut · doi:10.1136/gutjnl-2023-329543 · Cited by 312
Dual Role of Indoles Derived From Intestinal Microbiota on Human Health
Ye, X., Li, H., Anjum, K., Zhong, X., Miao, S., Zheng, G., Liu, W., & Li, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.903526 · Cited by 278
Metadata
- Authors
- Modoux, M., Rolhion, N., Mani, S., & Sokol, H.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 42
- Issue
- 1
- Pages
- 60-73
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W3107747122
- Cited by
- 284
- References
- 106
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.